Xibing Zhuang Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2024	Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients.
1/2022	Antidepressants Fluoxetine Mediates Endoplasmic Reticulum Stress and Autophagy of Non-Small Cell Lung Cancer Cells Through the ATF4-AKT-mTOR Signaling Pathway.
1/2022	Myeloid-Derived Suppressor Cells and CD68+CD163+M2-Like Macrophages as Therapeutic Response Biomarkers Are Associated with Plasma Inflammatory Cytokines: A Preliminary Study for Non-Small Cell Lung Cancer Patients in Radiotherapy.
1/2021	Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.
1/2020	Acetyl-11-Keto-β-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells.
10/2017	Analgecine enhances the anti-tumor response of radiotherapy by increasing apoptosis and cell cycle arrest in non-small cell lung cancer.
11/2016	Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
1/2016	High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells.
1/2016	Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment.
1/2015	CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xibing Zhuang Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 01/2013
13	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2013
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2015
10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023 - 01/2022
3	Thrombocytopenia (Thrombopenia) 12/2023 - 01/2023
3	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 01/2022
3	Lung Injury 01/2022 - 02/2016
2	Stomach Neoplasms (Stomach Cancer) 05/2019 - 05/2018
2	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2016
1	Inflammation (Inflammations) 12/2023
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 12/2023
1	Infections 09/2022
1	Adenocarcinoma 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Rhabdomyosarcoma 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Fibrosis (Cirrhosis) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Adenocarcinoma of Lung 10/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016

Drug/Important Bio-Agent (IBA)

9	Inosine Triphosphate (ITP)IBA 12/2023 - 01/2022
6	OligodeoxyribonucleotidesIBA 04/2018 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
4	Toll-Like Receptor 9IBA 04/2018 - 01/2013
4	CPG-oligonucleotideIBA 04/2018 - 01/2013
2	LipidsIBA 05/2024 - 11/2023
2	CytokinesIBA 12/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 12/2023 - 12/2023
2	Decitabine FDA Link 01/2023 - 01/2021
2	Cancer VaccinesIBA 01/2022 - 01/2019
2	AntigensIBA 01/2022 - 01/2019
2	VaccinesIBA 01/2022 - 01/2019
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2019
2	AcidsIBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
2	gingerolIBA 05/2019 - 05/2018
2	Nadroparin (Nadroparin Calcium)IBA 01/2018 - 10/2016
2	CytosineIBA 01/2016 - 01/2013
2	GuanineIBA 01/2016 - 01/2013
2	Phosphates (Orthophosphate)IBA 01/2016 - 01/2013
1	AlcoholsIBA 05/2024
1	AmidesIBA 05/2024
1	Carboxylic AcidsIBA 05/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2024
1	HydrocarbonsIBA 05/2024
1	Peptides (Polypeptides)IBA 05/2024
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2023
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2023
1	Lipoproteins (Lipoprotein)IBA 11/2023
1	ApolipoproteinsIBA 11/2023
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 09/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	Core Binding Factor Alpha 3 SubunitIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	FrankincenseIBA 01/2021
1	boswellic acidIBA 01/2020
1	TriterpenesIBA 01/2020
1	Sincalide FDA Link 05/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	PolyproteinsIBA 04/2018
1	Tumor Suppressor Protein p53IBA 04/2018
1	Mitogen-Activated Protein Kinase 14IBA 04/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	StreptavidinIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 11/2016
1	Docetaxel (Taxotere)FDA Link 11/2016
1	Pyruvate KinaseIBA 11/2016
1	SurvivinIBA 10/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Interleukin-12 (IL 12)IBA 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	CpG ODN 1826IBA 01/2013

Therapy/Procedure

12	Radiotherapy 01/2024 - 01/2015
8	Therapeutics 05/2024 - 01/2013
2	Precision Medicine 05/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 05/2019 - 01/2013
2	Aftercare (After-Treatment) 10/2016 - 01/2013